π΅οΈ Solesence, Inc. ($SLSN)
SEC insider & ownership activity, last 12 months Β· CIK 883107 Β· every row links its SEC filing
Over the last 12 months insiders bought $68K with no open-market selling against it. Whitmore R Janet bought $68K (NovβDec). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $68K (7 lots) Β· 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Whitmore R Janet | 7 | $68K | 0 | β | Dec 24, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Bradford T. Whitmore | 71.0% | 13D | May 29, 2025 | filing β | |
| Whitmore Holdings, LLC | 70.9% | 13D | May 29, 2025 | filing β | |
| Bradford Whitmore Trust | 70.9% | 13D | May 29, 2025 | filing β | |
| Strandler, LLC | 43.3% | 13D | May 29, 2025 | filing β |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jul 6, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Jul 6, 2026 | filing β |
| Earnings (2.02) | May 12, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | May 12, 2026 | filing β |
| Officer/director changes (5.02) | Apr 24, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Apr 24, 2026 | filing β |
| Earnings (2.02) | Mar 31, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Mar 31, 2026 | filing β |
| Officer/director changes (5.02) | Nov 24, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Nov 24, 2025 | filing β |
| Material agreement (1.01) | Nov 21, 2025 | filing β |
| Officer/director changes (5.02) | Nov 21, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Nov 21, 2025 | filing β |
| Earnings (2.02) | Nov 11, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Nov 11, 2025 | filing β |
| Material agreement (1.01) | Nov 6, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing β |
| Material agreement (1.01) | Sep 3, 2025 | filing β |
| Officer/director changes (5.02) | Sep 3, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Sep 3, 2025 | filing β |
| Shareholder vote (5.07) | Aug 28, 2025 | filing β |
| Earnings (2.02) | Jul 31, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Jul 31, 2025 | filing β |